BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31874730)

  • 1. Acute Generalized Exanthematous Pustulosis Caused by the Combination of Pembrolizumab Plus Chemotherapy in a Patient With Squamous-Cell Carcinoma.
    Matsubara T; Uchi H; Haratake N; Takamori S; Toyozawa R; Miura N; Yamaguchi M; Seto T; Takenoyama M
    Clin Lung Cancer; 2020 Mar; 21(2):e54-e56. PubMed ID: 31874730
    [No Abstract]   [Full Text] [Related]  

  • 2. Extrinsic Upregulation of PD-L1 Induced by Pembrolizumab Combination Therapy in Patients with NSCLC with Low Tumor PD-L1 Expression.
    Kunimasa K; Nakamura H; Nishino K; Nakatsuka SI; Kumagai T
    J Thorac Oncol; 2019 Oct; 14(10):e231-e233. PubMed ID: 31558236
    [No Abstract]   [Full Text] [Related]  

  • 3. Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer.
    Mazieres J; Kowalski D; Luft A; Vicente D; Tafreshi A; Gümüş M; Laktionov K; Hermes B; Cicin I; Rodríguez-Cid J; Wilson J; Kato T; Ramlau R; Novello S; Reddy S; Kopp HG; Piperdi B; Li X; Burke T; Paz-Ares L
    J Clin Oncol; 2020 Jan; 38(3):271-280. PubMed ID: 31751163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous Cell Carcinoma Transformation as a Possible Resistant Mechanism Against Pembrolizumab Plus Chemotherapy.
    Kozuma Y; Toyokawa G; Shoji F; Yamazaki K; Kawauchi S; Momosaki S; Takeo S
    J Thorac Oncol; 2019 Oct; 14(10):e238-e240. PubMed ID: 31558240
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US.
    Insinga RP; Vanness DJ; Feliciano JL; Vandormael K; Traore S; Ejzykowicz F; Burke T
    Curr Med Res Opin; 2019 Jul; 35(7):1241-1256. PubMed ID: 30649973
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis: clinical characteristics, etiologic associations, treatments, and outcomes in a series of 28 patients at Mayo Clinic, 1996-2013.
    Alniemi DT; Wetter DA; Bridges AG; El-Azhary RA; Davis MD; Camilleri MJ; McEvoy MT
    Int J Dermatol; 2017 Apr; 56(4):405-414. PubMed ID: 28084022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.
    Gadgeel SM; Stevenson JP; Langer CJ; Gandhi L; Borghaei H; Patnaik A; Villaruz LC; Gubens M; Hauke R; Yang JC; Sequist LV; Bachman R; Saraf S; Raftopoulos H; Papadimitrakopoulou V
    Lung Cancer; 2018 Nov; 125():273-281. PubMed ID: 30429032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute generalized exanthematous pustulosis induced by celecoxib.
    Lee SK; Lee DY; Kim DJ; Kim MS; Lee UH; Hahm JH
    J Cutan Pathol; 2016 Jan; 43(1):80-1. PubMed ID: 26488335
    [No Abstract]   [Full Text] [Related]  

  • 9. Complete response of recurrent squamous cell carcinoma of the lung: dose the dose matter?
    Shin S; Kim KJ; Lee YJ; Choi HJ; Kim H; Kim JH; Cho BC
    J Thorac Oncol; 2009 Jan; 4(1):141-2. PubMed ID: 19096325
    [No Abstract]   [Full Text] [Related]  

  • 10. Dynamics of blood neutrophil-related indices during nivolumab treatment may be associated with response to salvage chemotherapy for non-small cell lung cancer: A hypothesis-generating study.
    Soda H; Ogawara D; Fukuda Y; Tomono H; Okuno D; Koga S; Taniguchi H; Yoshida M; Harada T; Umemura A; Yamaguchi H; Mukae H
    Thorac Cancer; 2019 Feb; 10(2):341-346. PubMed ID: 30582295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Generalized Exanthematous Pustulosis Induced by Docetaxel and Recurrent With Letrozole: A Case Report.
    Sarradin V; Dalenc F; Sibaud V; Tournier E; Roché H
    Clin Breast Cancer; 2018 Oct; 18(5):e743-e746. PubMed ID: 29980428
    [No Abstract]   [Full Text] [Related]  

  • 12. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
    Akiyama N; Karayama M; Inui N; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Enomoto N; Nakamura Y; Inami N; Matsuura S; Kaida Y; Uto T; Matsui T; Asada K; Matsuda H; Fujii M; Toyoshima M; Suda T
    Invest New Drugs; 2019 Jun; 37(3):531-537. PubMed ID: 30790149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized phase II study of cetuximab and bevacizumab in combination with two regimens of paclitaxel and carboplatin in chemonaive patients with stage IIIB/IV non-small-cell lung cancer.
    Bonomi PD; Mace J; Mandanas RA; Min M; Olsen M; Youssoufian H; Katz TL; Sheth G; Lee HJ
    J Thorac Oncol; 2013 Mar; 8(3):338-45. PubMed ID: 23370316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-like generalized pustulosis induced by adalimumab.
    Suga H; Sugaya M; Tamaki Z; Yamamoto M; Tada Y; Sato S
    Int J Dermatol; 2013 Jul; 52(7):890-2. PubMed ID: 23789608
    [No Abstract]   [Full Text] [Related]  

  • 15. An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.
    Spigel DR; Luft A; Depenbrock H; Ramlau R; Khalil M; Kim JH; Mayo C; Chao GY; Obasaju C; Natale R
    Clin Lung Cancer; 2017 Sep; 18(5):480-488. PubMed ID: 28365238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motesanib plus carboplatin/paclitaxel in patients with advanced squamous non-small-cell lung cancer: results from the randomized controlled MONET1 study.
    Novello S; Scagliotti GV; Sydorenko O; Vynnychenko I; Volovat C; Schneider CP; Blackhall F; McCoy S; Hei YJ; Spigel DR
    J Thorac Oncol; 2014 Aug; 9(8):1154-61. PubMed ID: 25157768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical investigation of efficacy of albumin bound paclitaxel plus platinum compounds as first-line chemotherapy for stage III/IV squamous non-small cell lung cancer.
    Fang Y; Wang L; Xia GH; Shi MQ
    Asian Pac J Cancer Prev; 2014; 15(17):7453-7. PubMed ID: 25227858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermoscopy as an auxiliary tool in the early differential diagnosis of acute generalized exanthematous pustulosis (AGEP) and exanthematous (morbilliform) drug eruption.
    Errichetti E; Pegolo E; Stinco G
    J Am Acad Dermatol; 2016 Feb; 74(2):e29-31. PubMed ID: 26775791
    [No Abstract]   [Full Text] [Related]  

  • 19. First case report of acute generalized exanthematous pustulosis (AGEP) caused by mifepristone.
    Zhang L; Qian M; Hong L; Wu Q
    Contact Dermatitis; 2020 Mar; 82(3):177-179. PubMed ID: 31626328
    [No Abstract]   [Full Text] [Related]  

  • 20. [A Case of Squamous Cell Lung Cancer in an Elderly Patient with Low PD-L1 Expression Effectively Treated with Nab-Paclitaxel(Nab-PTX)plus Carboplatin (CBDCA)plus Pembrolizumab for a Recurrence after Operation].
    Sakaguchi K; Kosaka M; Yamazaki Y
    Gan To Kagaku Ryoho; 2020 May; 47(5):819-821. PubMed ID: 32408327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.